Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications-Reference-Cited by-同舟云学术

Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications

Published:2019-09-26 Issue:1-3 Volume:39 Page:258-269
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides & Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides & Nucleic Acids

Author:

Kojima Naoshi¹^ORCID,Shrestha Ajaya R.²,Akisawa Takuya²,Piao Haishun²,Kizawa Hideki²,Ohmiya Yoshihiro¹,Kurita Ryoji¹^ORCID

Affiliation:

1. Biomedical Research Institute, DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), and DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan;

2. Rena Therapeutics Inc., Shonan Health Innovation Park, Fujisawa, Japan

Publisher

Informa UK Limited

Subject

Genetics,Molecular Medicine,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15257770.2019.1668563

Reference30 articles.

1. Antisense therapy for cancer

2. Antisense therapies for cancer

3. Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA Antisense Able to Induce Dystrophin Exon 51 Skipping

4. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy

5. Antisense oligonucleotides in therapy for neurodegenerative disorders

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells;Advanced Science;2023-01-13

2. Synthesis and Exploitation of the Biological Profile of Novel Guanidino Xylofuranose Derivatives**;ChemMedChem;2022-05-31

3. Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences;Molecules;2021-03-19